| Literature DB >> 33867985 |
Fei Tang1, Hong-Ling Yan1, Li-Xia Wang1, Jin-Feng Xu1, Cheng Peng1, Hui Ao2, Yu-Zhu Tan1.
Abstract
For decades, chronic diseases including cardiovascular and cerebrovascular diseases (CCVDs) have plagued the world. Meanwhile, we have noticed a close association between CCVDs and vascular lesions, such as hypertension. More focus has been placed on TMPs and natural products with vasodilation and hypotension. TMPs with vasodilatory and hypotensive activities are mainly from Compositae, Lamiaceae, and Orchidaceae (such as V. amygdalina Del., T. procuinbens L., M. glomerata Spreng., K. galanga L., etc.) whereas natural products eliciting vasorelaxant potentials were primarily from flavonoids, phenolic acids and alkaloids (such as apigenin, puerarin, curcumin, sinomenine, etc.). Furthermore, the data analysis showed that the vasodilatory function of TMPs was mainly concerned with the activation of eNOS, while the natural products were primarily correlated with the blockage of calcium channel. Thus, TMPs will be used as alternative drugs and nutritional supplements, while natural products will be considered as potential therapies for CCVDs in the future. This study provides comprehensive and valuable references for the prevention and treatment of hypertension and CCVDs and sheds light on the further studies in this regard. However, since most studies are in vitro and preclinical, there is a need for more in-depth researches and clinical trials to understand the potential of these substances.Entities:
Keywords: cardiovascular and cerebrovascular diseases; mechanism; natural products; traditional medicinal plants; vasodilation
Year: 2021 PMID: 33867985 PMCID: PMC8048554 DOI: 10.3389/fphar.2021.627458
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Routes of vasodilation mechanisms. Red words denote common blockers of the corresponding pathways. eNOs, endothelial nitric oxide synthase; SGC, soluble guanylyl cyclase; cGMP, cyclic 3′,5′-guanosine monophosphate; PA 2, phospholipase A 2; AA, arachidonic acid; PGI2, prostaglandin 2; cAMP, cyclic adenosine 3′, 5′-monophosphate; β2-AR, β2-adrenoreceptor; PLC, phospholipase C; L-NAME, nitro-L-arginine; ODQ, 1H- [1, 2, 4] oxadiazolo [4, 3-α] quinoxalin-1-one; MB, methylene blue; INDO, indomethacin; PRO, propranolol; ATR, atropine; NI, nifedipine; GLI, glibenclamide; 4-AP, 4-aminopyridine; TEA, tetraethylammonium.
FIGURE 2The ratio of TMPs and natural products. (A): ratio of TMPs in this article (classified by family); (B): ratio of natural products in this article (classified by compound type).
FIGURE 3Some mechanisms of vasodilation caused by TMPs and natural products. (A) Vasodilation mechanism of TMPs; (B) Vasodilation mechanism of Natural Products. The vasodilatory function of TMPs was mainly concerned with the activation of eNOs, while the natural products were primarily associated with blockage of calcium channel. They also act on other pathways, including sGC-cGMP, potassium channels, muscarinic receptors, cyclooxygenase pathways, prostaglandin I2, etc.
FIGURE 4Natural products with significant vasodilation effect.
FIGURE 5Clinical application of some TMPs and natural products. The vasodilating TMPs and natural products are mainly used in the treatment of diabetes, hypertension, hyperlipidemia and some encephalopathy in the clinic.